Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Getsios

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Drugs & Aging|August 4, 2004
Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countriesJaime Caro, Maribel Salas, Alexandra Ward, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Economic burden of pertussis and the impact of immunizationJ Jaime Caro, Denis Getsios, Krista Payne, et al.
BMC Neurology|August 20, 2002
To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?Jaime Caro, Alexandra Ward, Khajak Ishak, et al.
Plos One|July 17, 2009
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effectsLaurent Coudeville, Annelies Van Rie, Denis Getsios, et al.
Pharmacoeconomics|August 16, 2014
Evaluating disease-modifying agents: a simulation framework for Alzheimer's diseaseShien Guo, Denis Getsios, Nikhil Revankar, et al.
Clinical Therapeutics|July 16, 2003
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United StatesKristen Migliaccio-Walle, Denis Getsios, J Jaime Caro, et al.
International Journal of Alzheimer'S Disease|January 18, 2013
Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data GapsShien Guo, Denis Getsios, Luis Hernandez, et al.
Journal of Medical Economics|June 19, 2015
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the USCatherine Saint-Laurent Thibault, Ipek Özer Stillman, Stephanie Chen, et al.
BMC Health Services Research|December 4, 2012
Accounting for the relationship between per diem cost and LOS when estimating hospitalization costsK Jack Ishak, Marilyn Stolar, Ming-yi Hu, et al.
BMC Public Health|July 3, 2007
Invasive meningococcal disease epidemiology and control measures: a framework for evaluationJ Jaime Caro, Jörgen Möller, Denis Getsios, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Drugs & Aging|August 4, 2004
Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countriesJaime Caro, Maribel Salas, Alexandra Ward, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Economic burden of pertussis and the impact of immunizationJ Jaime Caro, Denis Getsios, Krista Payne, et al.
BMC Neurology|August 20, 2002
To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?Jaime Caro, Alexandra Ward, Khajak Ishak, et al.
Plos One|July 17, 2009
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effectsLaurent Coudeville, Annelies Van Rie, Denis Getsios, et al.
Pharmacoeconomics|August 16, 2014
Evaluating disease-modifying agents: a simulation framework for Alzheimer's diseaseShien Guo, Denis Getsios, Nikhil Revankar, et al.
Clinical Therapeutics|July 16, 2003
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United StatesKristen Migliaccio-Walle, Denis Getsios, J Jaime Caro, et al.
International Journal of Alzheimer'S Disease|January 18, 2013
Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data GapsShien Guo, Denis Getsios, Luis Hernandez, et al.
Journal of Medical Economics|June 19, 2015
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the USCatherine Saint-Laurent Thibault, Ipek Özer Stillman, Stephanie Chen, et al.
BMC Health Services Research|December 4, 2012
Accounting for the relationship between per diem cost and LOS when estimating hospitalization costsK Jack Ishak, Marilyn Stolar, Ming-yi Hu, et al.
BMC Public Health|July 3, 2007
Invasive meningococcal disease epidemiology and control measures: a framework for evaluationJ Jaime Caro, Jörgen Möller, Denis Getsios, et al.
Pageof 4